In the resedigned website of CancerWorld we decided to have a special place for contributions from readers willing to comment on the topics covered, or propose topics that they feel are not enough covered or [more]
We at ESO are turning important pages in the history of our service to the European cancer community. We now invite you to turn the pages of Cancer World, which we hope you will find [more]
Almost four in ten serious adverse drug reactions now listed in the labels of 12 targeted cancer therapies were not mentioned in the studies that led to their approval. Half the serious reactions that were [more]
New knowledge favours promoting peace over waging war The world spends billions on trench warfare with cancer and makes slow progress with heavy collateral damage. New knowledge about the process of carcinogenesis and tumour growth [more]
First he was a pupil, then he joined the faculty. Now Fedro Peccatori has taken charge of ESO’s entire educational programme, and he knows exactly where he wants to take it. “There is no difference [more]
The revised European Cancer Code, launched last October, gives clear and concise information on what people can do to lower their own cancer risk. But until policy makers – and doctors – take prevention more [more]
This egrandround was first presented by Caroline Moore, from University College Hospital London, as a live webcast for the European School of Oncology. It is edited by Susan Mayor. The webcast of this and other [more]
Flexibility and goodwill have allowed patient involvement in the work of Europe’s drug regulators to develop at an impressive pace. But will they be enough to withstand the strains on the relationship exerted by financial [more]
The world is experiencing new and powerful forces in global health, from the Sustainable Development Goals, and ‘grand convergences’ to what is now the central totem in global health – universal health coverage. For cancer [more]
Every two years the metastatic breast cancer community convenes to assess what needs to be done to bridge gaps – gaps in scientific/clinical knowledge and in service provision, and gaps between the patients and professional [more]
The impact chemotherapy can have on the ability to think clearly is well recognised. Less is known, however, about the cognitive effect of endocrine therapies, which in the adjuvant breast cancer setting are being prescribed [more]